The burden of diabetes and hyperlipidemia in treated HIV infection and approaches for cardiometabolic care (Q38023235)

27 August 2017

title

The burden of diabetes and hyperlipidemia in treated HIV infection and approaches for cardiometabolic care (English)

1 reference

27 August 2017

1 reference

Katherine Samaras

1

1 reference

27 August 2017

publication date

1 September 2012

1 reference

27 August 2017

published in

Current HIV/AIDS reports

1 reference

27 August 2017

volume

9

1 reference

27 August 2017

issue

3

1 reference

27 August 2017

page(s)

206-217

1 reference

Diagnosis and classification of diabetes mellitus

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Severe hyperglycemia in an HIV clinic: preexisting versus drug-associated diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Incident hyperglycaemia among older adults with or at-risk for HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Disorders of glucose metabolism among HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Case-control study of diabetes mellitus in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Single-dose lopinavir-ritonavir acutely inhibits insulin-mediated glucose disposal in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Boosting dose ritonavir does not alter peripheral insulin sensitivity in healthy HIV-seronegative volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

The protease inhibitor combination lopinavir/ritonavir does not decrease insulin secretion in healthy, HIV-seronegative volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

An objective case definition of lipodystrophy in HIV-infected adults: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Management of fat accumulation in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

The prevalence and pathogenesis of diabetes mellitus in treated HIV-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Prevalence and pathogenesis of diabetes mellitus in HIV-1 infection treated with combined antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

The impact of HIV/AIDS on Type 2 diabetes prevalence and diabetes healthcare needs in South Africa: projections for 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

The burden of metabolic diseases amongst HIV positive patients on HAART attending The Johannesburg Hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Diabetes mellitus and HIV as co-morbidities in tuberculosis patients of rural south India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Lipid metabolism in treated HIV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Studies of adipose tissue metabolism in human immunodeficiency virus-associated lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Proinflammatory markers, insulin sensitivity, and cardiometabolic risk factors in treated HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Urinary albumin excretion within the normal range is an independent risk for near-term development of kidney disease in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Prevalence of diabetic retinopathy, cataract and visual impairment in patients with diabetes in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Standards of medical care in diabetes--2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Assessment of the quality of diabetes care for HIV-infected patients in a national health care system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Glycemic control in HIV-infected patients with diabetes mellitus and rates of meeting American Diabetes Association management guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

South Asian Consensus Guidelines for the rational management of diabetes in human immunodeficiency virus/acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

HIV infection, aging and cardiovascular disease: epidemiology and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Combination antiretroviral therapy and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Adverse outcome analyses of observational data: assessing cardiovascular risk in HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Abacavir use and cardiovascular disease events: a meta-analysis of published and unpublished data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Dietary intervention prevents dyslipidemia associated with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected individuals: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Elevated triglycerides and risk of myocardial infarction in HIV-positive persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Prevalence of diabetes mellitus, hyperinsulinaemia and metabolic syndrome among 755 adult patients with HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Disorders of fat partitioning in treated HIV-infection

21 January 2018

1 reference

12 December 2020

Small Dense Lipoproteins, Apolipoprotein B, and Risk of Coronary Events in HIV-Infected Patients on Antiretroviral Therapy

1 reference

12 December 2020

Hypertriglyceridemia and waist circumference predict cardiovascular risk among HIV patients: a cross-sectional study

1 reference

12 December 2020

Increased prevalence of albuminuria in HIV-infected adults with diabetes

1 reference

12 December 2020

Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors

1 reference

12 December 2020

Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors

1 reference

12 December 2020

Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection

1 reference

12 December 2020

Are HIV patients undertreated? Cardiovascular risk factors in HIV: results of the HIV-HEART study

1 reference

12 December 2020

Severe diabetes associated with protease inhibitor therapy

1 reference

12 December 2020

The heart of the matter: cardiometabolic care in youth with psychosis.

1 reference

12 December 2020

Protease inhibitor-associated hyperglycaemia

1 reference

12 December 2020

New-onset diabetes mellitus associated with use of protease inhibitor

1 reference

12 December 2020

10.1007/S11904-012-0124-X

Identifiers

DOI

1 reference

27 August 2017

1 reference